All Articles

In a bold strategic move, ivari is bundling on-demand healthcare with life insurance, signaling a market shift from passive protection to proactive wellness.

After teetering on the brink, AeroFarms' acquisition by a patient investor signals a crucial shift for the entire vertical farming sector, from VC hype to profitability.

The education giant swung from a massive loss to profit, not on textbooks, but on a strategic pivot to recurring digital revenue and a big bet on AI.

Binance's spot on the Fortune Crypto 100 is a mainstream win, but it masks a deeper story of regulatory battles and a high-stakes pivot to a financial super app.

Major academic centers no longer hold a monopoly on medical breakthroughs. A look at how community networks are democratizing cutting-edge cancer research.

Firat Eren rebuilt the cult-favorite barter app Bunz from the ashes. Now, he's given its users until September 1st to prove it's worth saving, or he'll delete it himself.

Bespin Global US's debut on the CRN SP500 is more than a press release. It's a signal of a market grappling with cloud costs, AI, and the need for new experts.

LiTime’s new Xtra Mini batteries are 40% smaller but promise EV-grade durability, signaling a major shift in how we power our mobile lives.

Famed design firm Whipsaw is expanding beyond blueprints, hiring Roomba launch veteran Nancy Smith to build a new practice aimed at solving a key industry flaw.

Sweeping data from EHA 2026 shows Syndax's Revuforj achieving remarkable success across leukemia settings, signaling a new standard of care and a major market coup.

A new currency vending machine in Saskatoon is more than a convenience; it's a signal of automation's next frontier in the battle for travel dollars.

Yardi's long-running Changemakers sponsorship isn't just PR. It's a strategic investment to guide a market in flux and cement its role as an industry architect.

Relmada Therapeutics poaches a Sage neurosteroid expert for its sepranolone program. A look at the strategic rationale behind a move that signals big ambitions.

New data on an all-oral combo therapy for AML shows remarkable efficacy, offering new hope for patients and cementing Syndax's competitive advantage.

Elwood's integration with Kalshi isn't just a tech deal; it's a growth signal that prediction markets are getting the institutional rails they need to grow up.

Stunning head-to-head trial data shows Takeda's zasocitinib is 2.5x more effective than its rival, signaling a major market disruption and validating a landmark deal.

With Thomas Winstanley at the helm, Edibles.com eyes dominance in the wellness-THC space. Can his CPG playbook conquer a booming but volatile market?

Cognizant's partnership with Oracle to deploy AI in recruiting highlights a critical trend: using automation to manage vast workforces and win the war for talent.

GiantLeap Capital's investment in Standard Bots signals a new era for U.S. manufacturing, where AI-native robots are key to productivity and security.

Cable giants are spending billions on DOCSIS 4.0 and Wi-Fi 7 to deliver mind-bending speeds. But as a new report shows, this global speed war may deepen the digital divide.